Loading…
Loading…
GSAC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for GSAC and 80,000+ other tickers.
See exactly how GSAC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GSAC and 80,000+ other tickers.
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat…
GelStat's Subsidiary Awarded Renewal for Security Monitoring Services and Expands Deployment of Proprietary iCAS Technology Across Three Secure Government-Operated Facilities in Florida GelStat's Subsidiary Awarded Renewal for Security Monitoring Services and Expands Deployment of Proprietary iCAS Technology Across Three Secure Government-Operated Facilities in Florida
GelStat's Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market GelStat's Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market